Unipharsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-08-17
Share capital
50,000.00 PLN
Registered address
Bażancia 34, 02-892 Warszawa, Poland
Website

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 398 days for 2019).

  • 2025not filed
  • 202430/07/2025
  • 202322/09/2024
  • 202228/09/2023
  • 202122/04/2022
  • 202008/11/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 4.13mMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD 37.84kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 3.89mMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 3.38mMedianUSD 883.09kAverageUSD 31.39m

Trademarks

Uniphar holds 15 active trademarks registered with the Polish Patent Office. 8 marks have expired or were not registered. The first mark was filed in 2008.

MarkNumberClassesStatusProtected until
Dobry Sen MELATORINZ.5170885Protected Aug 13, 2030
ESSE-HEPAR(word)Z.4996975Protected May 13, 2029
ASPARAGINIAN dobrze Ci zrobi!Z.4904295Protected Sep 12, 2028
MAGNEZ cytrynowyZ.4786935Protected Nov 7, 2027
SuperSalt salt plusZ.4708005, 30Protected Apr 24, 2027
MarkProtected until
Dobry Sen MELATORINAug 13, 2030
ESSE-HEPAR(word)May 13, 2029
ASPARAGINIAN dobrze Ci zrobi!Sep 12, 2028
MAGNEZ cytrynowyNov 7, 2027
SuperSalt salt plusApr 24, 2027

Authorized Representatives

Grzegorz Kobyłczyk – Vice President of the Management Board
Jan Józef Włodarczyk – President of the Management Board
Krzysztof Włodarczyk – Pierwszy Wiceprezes Zarządu
Roman Śleboda – Vice President of the Management Board

Manner of representation

The company may be represented and declarations of will may be made and signed on behalf of the company by: the President of the Management Board or the First Vice-President of the Management Board independently; or three members of the management board or Vice-Presidents of the Management Board acting jointly; or two members of the management board or Vice-Presidents of the Management Board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Jan Józef Włodarczykage 87
50$6,753.1150%
Krzysztof Włodarczykage 62
50$6,753.1150%

Jan Józef Włodarczyk and Krzysztof Włodarczyk hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2004-10-25.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

14 public aid cases recorded, with a total value of $392,267.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cefea sp. z o.o.sp. k.
MedicofarmaS.A.
Biovena Healthsp. z o.o.
VitamaS.A.
Noris Polskasp. z o.o.
Langsteinersp. z o.o.
Komarkosp. z o.o.
2care4 Polandsp. z o.o.
Actifarmsp. z o.o.
Medifarsp. z o.o.

Change history

DateEvent
2022-01-04PKD change
2010-10-29Name change
2010-10-29Switch to PKD 2007
2004-08-17Entered in the register

FAQ

Last updated: 2026-10-04